Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Taprogge

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Physics in Medicine and Biology|December 29, 2021
Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapyJohan Gustafsson, Jan Taprogge
EJNMMI Physics|February 5, 2025
On the reduction of imaging time-points for dosimetry in radionuclide therapyJohan Gustafsson, Jan Taprogge
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 25, 2023
Future trends for patient-specific dosimetry methodology in molecular radiotherapyJohan Gustafsson, Jan Taprogge
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 19, 2019
Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancerJan Taprogge, Francesca Leek, Glenn D Flux
EJNMMI Physics|January 9, 2019
Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimationJonathan I Gear, Jan Taprogge, Owen White, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 12, 2023
Radiation protection aspects for alpha therapiesAllison J Craig, Jan Taprogge, Glenn D Flux, et al.
Seminars in Nuclear Medicine|December 28, 2021
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer TherapyGlenn Flux, Francesca Leek, Paul Gape, et al.
EJNMMI Physics|December 13, 2022
Quantification and dosimetry of small volumes including associated uncertainty estimationLily Carnegie-Peake, Jan Taprogge, Iain Murray, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|July 14, 2021
Adjustment of the iodine ICRP population pharmacokinetic model for the use in thyroid cancer patients after thyroidectomyJan Taprogge, Lily Carnegie-Peake, Iain Murray, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2025
A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid CancerJan Taprogge, Iain Murray, Kate Newbold, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Physics in Medicine and Biology|December 29, 2021
Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapyJohan Gustafsson, Jan Taprogge
EJNMMI Physics|February 5, 2025
On the reduction of imaging time-points for dosimetry in radionuclide therapyJohan Gustafsson, Jan Taprogge
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 25, 2023
Future trends for patient-specific dosimetry methodology in molecular radiotherapyJohan Gustafsson, Jan Taprogge
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 19, 2019
Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancerJan Taprogge, Francesca Leek, Glenn D Flux
EJNMMI Physics|January 9, 2019
Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimationJonathan I Gear, Jan Taprogge, Owen White, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 12, 2023
Radiation protection aspects for alpha therapiesAllison J Craig, Jan Taprogge, Glenn D Flux, et al.
Seminars in Nuclear Medicine|December 28, 2021
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer TherapyGlenn Flux, Francesca Leek, Paul Gape, et al.
EJNMMI Physics|December 13, 2022
Quantification and dosimetry of small volumes including associated uncertainty estimationLily Carnegie-Peake, Jan Taprogge, Iain Murray, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|July 14, 2021
Adjustment of the iodine ICRP population pharmacokinetic model for the use in thyroid cancer patients after thyroidectomyJan Taprogge, Lily Carnegie-Peake, Iain Murray, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2025
A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid CancerJan Taprogge, Iain Murray, Kate Newbold, et al.
Pageof 2